Medifast Reports 36.9% Q4 Revenue Decline, $18.1M Net Loss, Boosts Coach Productivity
Medifast Inc reported fourth-quarter 2025 revenue down 36.9% year-over-year and a net loss of $18.1 million due to a $12.1 million non-cash valuation allowance and a 40.6% drop in active coaches. The company holds $167.3 million cash and achieved its first coach productivity increase since mid-2022 through new metabolic health programs.
1. Q4 Financial Results
In the fourth quarter of 2025, Medifast Inc recorded revenue down 36.9% year-over-year and a 40.6% decline in active earning coaches, resulting in a net loss of $18.1 million that included a $12.1 million non-cash valuation allowance. Gross profit margin contracted 470 basis points to 69.4% due to lower sales volumes and a one-time restructuring charge.
2. Coach Productivity and Program Initiatives
Medifast achieved its first year-over-year improvement in coach productivity since mid-2022 as coaches shifted to a metabolic health narrative. The launch of Premiere Plus and Edge programs has spurred higher coach-led meetings and training activities aimed at enhancing client engagement.
3. Balance Sheet and Outlook
The company exited the quarter with $167.3 million in cash and no debt, providing financial flexibility for growth initiatives. Management expects active earning coach counts to decline through most of 2026 but foresees stabilization and potential revenue improvement as productivity gains and new product introductions take effect.